cabozantinib
Showing 51 - 75 of 128
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 17, 2022
Old Age; Debility, Renal Carcinoma Metastatic Trial in Spain (Cabozantinib)
Recruiting
- Old Age; Debility
- Renal Carcinoma Metastatic
- Cabozantinib
-
Ciudad Real, Spain
- +9 more
Feb 8, 2022
Urothelial Carcinoma, Urethral Tumors, Urinary Bladder Tumors Trial run by the NCI (Cabozantinib)
Active, not recruiting
- Urothelial Carcinoma
- +3 more
- Cabozantinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021
Advanced Metastatic Melanoma Trial in Iowa City (Cabozantinib, Pembrolizumab)
Recruiting
- Advanced Metastatic Melanoma
- Cabozantinib
- Pembrolizumab
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Sep 13, 2021
Kidney Cancer, Renal Cell Carcinoma Trial in New Brunswick, New York, Cleveland (Cabozantinib, Nivolumab, Cytoreductive
Recruiting
- Kidney Cancer
- Renal Cell Carcinoma
- Cabozantinib
- +2 more
-
New Brunswick, New Jersey
- +2 more
Mar 22, 2022
Solid Tumor Trial in San Diego (Cabozantinib, 13-cis-retinoic acid)
Recruiting
- Solid Tumor
- Cabozantinib
- 13-cis-retinoic acid
-
San Diego, CaliforniaRady Children's Hospital - San Diego
Oct 6, 2021
Colorectal Cancer, Colorectal Carcinoma, Metastatic Cancer Trial in Orange (Cabozantinib, TAS-102)
Recruiting
- Colorectal Cancer
- +3 more
- Cabozantinib
- TAS-102
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Sep 30, 2021
Colorectal Adenocarcinoma, Colon Cancer, Colon Adenocarcinoma Trial in United States (Cabozantinib, Nivolumab)
Recruiting
- Colorectal Adenocarcinoma
- +6 more
- Cabozantinib
- Nivolumab
-
Aurora, Colorado
- +4 more
Nov 19, 2021
Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma Trial in Boston (Cabozantinib, Topotecan,
Recruiting
- Relapsed Ewing Sarcoma
- +3 more
- Cabozantinib
- +3 more
-
Boston, Massachusetts
- +1 more
Sep 27, 2021
Differentiated Thyroid Cancer (DTC), Poorly Differentiated Thyroid Cancer Trial in Philadelphia (Cabozantinib)
Active, not recruiting
- Differentiated Thyroid Cancer (DTC)
- Poorly Differentiated Thyroid Cancer
- Cabozantinib
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 7, 2021
Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma
Recruiting
- Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
- +6 more
- cabozantinib
- nivolumab
-
Basking Ridge, New Jersey
- +6 more
Feb 2, 2022
Metastatic Well Differentiated Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Milano (Cabozantinib, Lanreotide)
Recruiting
- Metastatic Well Differentiated Neuroendocrine Neoplasm
- Neuroendocrine Tumors
- Cabozantinib
- Lanreotide
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Sep 3, 2021
Locally Advanced Hepatocellular Carcinoma Trial in Baltimore (Cabozantinib, Nivolumab)
Active, not recruiting
- Locally Advanced Hepatocellular Carcinoma
- Cabozantinib
- Nivolumab
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Aug 18, 2021
Urothelial Carcinoma Trial in Mainz (Cabozantinib)
Terminated
- Urothelial Carcinoma
- Cabozantinib
-
Mainz, GermanyDepartment of Urology of the University Medical Center Mainz
Aug 24, 2021
Neuroendocrine Tumors,Gastroenteropancreatic Trial in Taipei (Cabozantinib, Lanreotide)
Not yet recruiting
- Neuroendocrine Tumors,Gastroenteropancreatic
- Cabozantinib
- Lanreotide
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 9, 2021
Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)
Not yet recruiting
- Solid Tumors With HRAS Alterations
- +4 more
- KO-2806
- Cabozantinib
- (no location specified)
Aug 30, 2023
Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia
Recruiting
- Renal Cell Carcinoma
- +5 more
- Cabozantinib
-
Albury, New South Wales, Australia
- +10 more
Feb 14, 2022
Collecting Duct Carcinoma (Kidney) Trial in Milan (cabozantinib)
Completed
- Collecting Duct Carcinoma (Kidney)
- cabozantinib
-
Milan, ItalyGiuseppe Procopio
May 7, 2021
Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma Trial in Houston
Active, not recruiting
- Differentiated Thyroid Gland Carcinoma
- +3 more
- Computed Tomography
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Feb 17, 2022
Hepatocellular Carcinoma, Recurrent Cancer, Liver Transplant Trial in Toronto (Cabozantinib)
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Cabozantinib
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 11, 2021
Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)
Active, not recruiting
- Locally Advanced or Metastatic Renal Cell Carcinoma
- Cabozantinib
-
Salzburg, Austria
- +39 more
Jan 18, 2023
Breast Cancer, Brain Tumor - Metastatic Trial in Boston (Cabozantinib, Trastuzumab)
Completed
- Breast Cancer
- Brain Tumor - Metastatic
- Cabozantinib
- Trastuzumab
-
Boston, Massachusetts
- +1 more
May 18, 2021
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 2, 2022
Salivary Gland Cancer Trial in Nijmegen (Cabozantinib)
Terminated
- Salivary Gland Cancer
- Cabozantinib
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Mar 11, 2021